Peroxiredoxin 5 links mitochondrial redox signalling with calcium dynamics: Impact on Parkinson's disease

Journal of Neurochemistry

Volumn 125, Issue 3, 2013, Pages 332-333

  Davey, Gavin P ^a   Bolaños, Juan P ^b  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 2 AMINOETHOXYDIPHENYLBORANE; 3 NITROTYROSINE; ADENOSINE TRIPHOSPHATE; CALCIUM CHANNEL L TYPE; CALCIUM ION; CASPASE 3; CASPASE 9; DANTROLENE; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; ISOENZYME; LACTATE DEHYDROGENASE; MITOCHONDRIAL DNA; NIMODIPINE; PEROXIREDOXIN 5; PROTEIN BAX; REACTIVE OXYGEN METABOLITE; RYANODINE RECEPTOR;

APOPTOSIS; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CALCIUM TRANSPORT; DNA DAMAGE; EDITORIAL; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; ENZYME RELEASE; HUMAN; MITOCHONDRION; MOLECULAR DYNAMICS; MOLECULAR MECHANICS; NEUROBLASTOMA CELL; NEUROPROTECTION; NONHUMAN; OXIDATION REDUCTION REACTION; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS;

ANIMALS; CALCIUM; ENZYME INHIBITORS; HUMANS; MITOCHONDRIA; OXIDATION-REDUCTION; PARKINSON DISEASE; PEROXIREDOXINS; SIGNAL TRANSDUCTION;

EID: 84876687264     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12171     Document Type: Editorial

References (7)

1. Bolaños J. P., and, Heales S. J., (2010) Persistent mitochondrial damage by nitric oxide and its derivatives: neuropathological implications. Front Neuroenergetics 2, 1.
2. +. Neurosci. Lett. 433, 219-224.
3. +-induced cell death. J. Neurochem. doi: 10.1111/jnc.12117.
4. Lee D. H., Han Y. S., Han E. S., Bang H., and, Lee C. S., (2006) Differential involvement of intracellular Ca2+ in 1-methyl-4-phenylpyridinium- or 6-hydroxydopamine-induced cell viability loss in PC12 cells. Neurochem. Res. 31, 851-860.
5. Qu D., Rashidian J., Mount M. P., et al,. (2007) Role of Cdk5-mediated phosphorylation of Prx2 in MPTP toxicity and Parkinson's disease. Neuron 55, 37-52.
6. Schapira A. H., Cooper J. M., Dexter D., Jenner P., Clark J. B., and, Marsden C. D., (1989) Mitochondrial complex I deficiency in Parkinson's disease. Lancet 1, 1269.
7. Telford J. E., Kilbride S. M., and, Davey G. P., (2009) Complex I is rate-limiting for oxygen consumption in the nerve terminal. J. Biol. Chem. 284, 9109-9114.